US Broker Ratings

argenx SE (ARGX) Stock Analysis: Exploring a 15.47% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a Netherlands-based biotechnology company, stands as a compelling player in the healthcare sector, boasting a market cap of $55.84 billion. Specializing in developing therapies for autoimmune..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 11.34% Potential Upside Amid Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a leader in the healthcare sector, continues to capture investor attention with its robust portfolio and promising financial outlook. Headquartered in North Chicago, Illinois, AbbVie focuses..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 31.52% Potential Upside in the Healthcare Market

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling opportunity for investors seeking exposure to the burgeoning..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 10.41% Upside in the Healthcare Giant

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products. With a market capitalization of $116.66 billion,..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 32% Potential Upside with Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a cornerstone for investors seeking a blend of stability and growth. With a market capitalization of $153.59..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 56.58% Upside Potential in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic industries, is drawing investor attention with its strong market position and..

Edwards Lifesciences (EW) Stock Analysis: Strong Buy Ratings Point to a 13.88% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry with a robust portfolio of cardiovascular products, remains a compelling choice for investors seeking growth in the healthcare..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Ratings and Nearly 9% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is drawing attention from investors with a compelling combination of robust growth metrics and a solid analyst consensus...

GSK plc (GSK) Stock Analysis: Unveiling a 6.77% Potential Upside Amid Robust Healthcare Portfolio

GSK plc (GSK) stands as a formidable entity within the healthcare sector, operating under the Drug Manufacturers – General industry. With a rich history dating back to 1715, GSK has..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 64% Potential Upside with Robust Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands at a pivotal point in the healthcare sector, particularly within the medical devices industry. With a substantial market capitalization of $69.72 billion, the company..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 25% Potential Upside Amid Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) remains a compelling choice for investors seeking opportunities within the healthcare sector. With a substantial market capitalization of $155.93 billion, this biopharmaceutical giant is making..

Eli Lilly (LLY) Stock Report: Navigating Growth with a 7.31% Upside Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture the attention of investors with its impressive market capitalization of $1.01 trillion. As a leading..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 65% Potential Upside in the Medical Devices Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) presents a compelling opportunity for investors within the healthcare sector, particularly in the niche of medical devices specializing in cardiac monitoring. With a market capitalization..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 110% Potential Upside in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention with its significant growth potential. With a market capitalization of $1.85 billion, this U.S.-based..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and a Promising 7.24% Potential Upside

Krystal Biotech, Inc. (KRYS), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to genetic medicine. As a commercial-stage biotechnology company, Krystal..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring the Healthcare Biotech Leader’s Steady Trajectory

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a key player in the biotechnology industry, has garnered significant attention from investors due to its strategic focus on developing treatments for rare diseases. With..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 69% Potential Upside with Strong Buy Ratings

Waystar Holding Corp. (WAY), a key player in the healthcare sector, specifically within health information services, is garnering attention from investors for its remarkable potential upside of 69.13%. Headquartered in..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech with a Promising 130% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, is capturing significant attention from investors with its robust pipeline of innovative vaccines and a compelling 130.15% potential upside. Despite its current..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, stands at a crossroads with a compelling case for investors seeking exposure to the drug manufacturing industry. Specializing in plasma-derived..

Cytokinetics, Inc. (CYTK) Stock Analysis: A Promising Biotech Player with Potential 46.47% Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a key player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach in the healthcare industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds